Prometheus shall Promote the Product in the Territory Sample Clauses

Prometheus shall Promote the Product in the Territory in accordance with the provisions of this Agreement, only under the ENTOCORT® xxxx and the other Trademarks; provided, however, that the labeling for the Product and the Promotional Materials shall contain the Prometheus corporate name and logo in accordance with the provisions of Section 9.2. From time to time, Prometheus may propose to AstraZeneca that an additional Xxxx be used in connection with the Promotion of the Product in the Territory. (For purposes of this Section 9.1, an additional Xxxx to be used solely in connection with the Promotion of the Product in the Territory is referred to as an "Additional Product Xxxx" and an additional Xxxx to be used in other aspects of Prometheus' business in addition to its use in connection with the Promotion of the Product in the Territory is referred to as a "Prometheus Xxxx"). No Additional Product Xxxx shall be used in connection with the Promotion of the Product in the Territory unless and until AstraZeneca, in its sole discretion, approves such Additional Product Xxxx for use in connection with the Promotion of the Product in writing in advance. Any Additional Product Xxxx so approved by AstraZeneca shall be deemed to be a Trademark for purposes of this Agreement, and Prometheus hereby assigns to AstraZeneca any right, title and interest in and to such Additional Product Marks. Prometheus shall not use a Prometheus Xxxx in connection with the Promotion of the Product in the Territory unless and until AstraZeneca consents, based on its Reasonable Business Judgment, to such use of such Xxxx for use in connection with the Promotion of the Product in writing in advance. AstraZeneca may not unreasonably withhold or delay such consent; provided that it shall not be unreasonable for AstraZeneca to withhold such consent in the event AstraZeneca believes in its Reasonable Business Judgment that use of such Prometheus Xxxx in connection with the Promotion of the Product in the Territory could reasonably be likely to cause a likelihood of confusion as to the source of the Product or with any Xxxx owned by AstraZeneca or could ***Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. reasonably be likely to dilute or cause harm to AstraZeneca's interests in the ENTOCORT® EC trademark or any of the other Trademarks, or AstraZeneca determines, in its Reasonable Business Judgment, ...
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs

Related to Prometheus shall Promote the Product in the Territory

  • Territory The territorial limits of this Agreement shall be identical with those of the Reinsured Contracts.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Manufacture of Product Prior to commercialization of the Product, the Parties may, if appropriate for both parties, negotiate in good faith a manufacturing and supply agreement to provide for Licensor to fulfill the manufacturing requirements of Licensee for Product for sale in the European market. The cost of such manufacturing shall not be greater than * percent (*%) of the cost of any competitor cGMP contract manufacturing facility that proposes to manufacturer the Product for Licensee. * Confidential information has been omitted and filed confidentially with the Securities and Exchange Commission.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Product The term “

Time is Money Join Law Insider Premium to draft better contracts faster.